Development of Complex Generics

Feb 4, 2020 | Delivery difficulties

The FDA has issued a statement to encourage the development of complex generics to provide access to patients and promote healthy competition.

https://www.europeanpharmaceuticalreview.com/news/83598/fda-generics/

BACK TO NEWS

Manage Cookie Consent

We use cookies to optimise our website and our service.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage vendors Read more about these purposes

Show settings

{title} {title} {title}

Development of Complex Generics

Categories